Iveco Group 2023 Third Quarter Results

The following is an extract from the “Iveco Group 2023 Third Quarter Results” press release. The complete press release can be accessed by visiting the media section of the Iveco Group corporate website: https://www.ivecogroup.com/media/corporate_press_releases or consulting the accompanying PDF:

Iveco Group consolidated revenues of €3.8 billion (up 7% year-on-year).

Adjusted EBIT of €213 million (up €112 million) and adjusted net income of €84 million.

Net cash of Industrial Activities at €725 million.

Full year 2023 financial guidance increased.

The Company announces its Capital Markets Day to be held 14th March 2024.

Consolidated revenues of €3,757 million, up 6.7%. Net revenues of Industrial Activities of €3,671 million, up 5.8%, mainly due to positive price realisation and better mix.

Adjusted EBIT of €213 million (€112 million increase compared to Q3 2022), with a 5.7% margin (up 280 bps compared to Q3 2022). Adjusted EBIT of Industrial Activities of €180 million (€64 million in Q3 2022) and margin at 4.9% (up 310 bps compared to Q3 2022), reflecting a strong price realisation in the quarter.

Adjusted net income of €84 million (€54 million increase compared to Q3 2022). Adjusted diluted earnings per share of €0.28 (up €0.18 compared to Q3 2022).

Financial expenses of 97 million (€65 million in Q3 2022), increasing mainly as a consequence of higher interest rates and the impact of hyperinflation accounting primarily in Argentina.

Reported income tax expense of €15 million, with adjusted effective tax rate (adjusted ETR) of 28% reflecting different tax rates applied in the jurisdictions where the Group operates and some other discrete items.

Net cash of Industrial Activities at €725 million (€1,727 million at 31st December 2022). Free cash flow of Industrial Activities negative for €375 million (negative for €232 million in Q3 2022) primarily due to higher working capital absorption partially offset by positive price realisation.

Available liquidity at €3,506 million as of 30th September 2023, down €258 million from 30th June 2023, including €2,000 million of undrawn committed facilities.

Attachment

GlobeNewswire Distribution ID 1000897022

LeddarTech Announces Participation in Upcoming Fourth Quarter 2023 Investor Conferences

QUEBEC CITY, Canada, Nov. 01, 2023 (GLOBE NEWSWIRE) — LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, announces that Frantz Saintellemy, President and Chief Operating Officer, is scheduled to participate in the following upcoming investor events:

LeddarTech will participate in meetings with potential investors and industry analysts and in fireside chats. For more information or to register, please visit the “Events & Presentations” section of LeddarTech’s investor relations website.

On June 13, 2023, Prospector Capital Corp. (“Prospector”) (NASDAQ: PRSR, PRSRU, PRSRW), a Cayman Islands exempted company led by former Qualcomm President Derek Aberle and chaired by former Qualcomm Vice Chairman Steve Altman, announced a definitive business combination agreement with LeddarTech. Upon closing of the transaction, which is expected during the fourth quarter of 2023, the combined company formed through the business combination, LeddarTech Holdings Inc. (“Newco”), is expected to be listed on the NASDAQ under the ticker symbol “LDTC.”

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech’s automotive-grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is available to OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle ADAS solutions.

LeddarTech is responsible for several remote-sensing innovations, with over 150 patent applications (80 granted) that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

Additional information about LeddarTech is accessible at www.LeddarTech.com and on LinkedIn, Twitter (X), Facebook and YouTube.

About Prospector Capital Corp.

Prospector is a special-purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses with a focus on companies with advanced and highly differentiated solutions for the technology sector. The company is led by a team of experienced investors and executives focused on identifying and investing in high-growth companies with strong management teams and attractive market opportunities. Prospector’s securities are traded on NASDAQ under the ticker symbols “PRSR,” “PRSRU” and “PRSRW.”

Important Information About the Proposed Transaction and Where to Find It

In connection with the proposed business combination, Prospector, LeddarTech and Newco will prepare and will file with the SEC the registration statement on Form F-4 (the “Registration Statement”), and Prospector will mail the proxy statement/prospectus contained within the Registration Statement to its shareholders and file other documents regarding the business combination with the SEC. This press release is not a substitute for any proxy statement, registration statement, proxy statement/prospectus or other documents Prospector or Newco may file with the SEC in connection with the business combination. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE REGISTRATION STATEMENT WHEN IT BECOMES AVAILABLE, ANY AMENDMENTS OR SUPPLEMENTS TO THE REGISTRATION STATEMENT AND OTHER DOCUMENTS FILED BY PROSPECTOR OR NEWCO WITH THE SEC IN CONNECTION WITH THE BUSINESS COMBINATION, BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Registration Statement and other documents filed with the SEC by Prospector or Newco through the website maintained by the SEC at www.sec.gov.

Forward-Looking Statements

Certain statements contained in this press release may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act (which forward-looking statements shall also include forward-looking statements and forward-looking information within the meaning of applicable Canadian securities laws), including, but not limited to, statements regarding the business combination involving Prospector, LeddarTech and Newco, the ability to consummate the business combination and the timing thereof, the anticipated benefits from the business combination, the closing of the private placement financing and expected proceeds therefrom and statements relating to Newco’s anticipated strategy, future operations, prospects, objectives and financial projections and other financial metrics. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the business combination are not satisfied, including the failure to timely or at all obtain shareholder approval for the business combination or the failure to timely or at all obtain any required regulatory clearances, including of the Superior Court of Justice of Québec; (ii) uncertainties as to the timing of the consummation of the business combination and the ability of each of Prospector, LeddarTech and Newco to consummate the business combination; (iii) the possibility that other anticipated benefits of the business combination will not be realized, and the anticipated tax treatment of the business combination; (iv) the occurrence of any event that could give rise to termination of the business combination; (v) the risk that shareholder litigation in connection with the business combination or other settlements or investigations may affect the timing or occurrence of the business combination or result in significant costs of defense, indemnification and liability; (vi) changes in general economic and/or industry-specific conditions; (vii) possible disruptions from the business combination that could harm LeddarTech’s business; (viii) the ability of LeddarTech to retain, attract and hire key personnel; (ix) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the business combination; (x) potential business uncertainty, including changes to existing business relationships, during the pendency of the business combination that could affect LeddarTech’s financial performance; (xi) legislative, regulatory and economic developments; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID-19), as well as management’s response to any of the aforementioned factors; (xiii) access to capital and financing and LeddarTech’s ability to maintain compliance with debt covenants; and (xiv) other risk factors as detailed from time to time in Prospector’s reports filed with the SEC, including Prospector’s Annual Report on Form 10-K, periodic Quarterly Reports on Form 10-Q, periodic Current Reports on Form 8-K and other documents filed with the SEC, as well as the risk factors to be contained in the Registration Statement. The foregoing list of important factors is not exhaustive. Neither Prospector nor LeddarTech can give any assurance that the conditions to the business combination will be satisfied. Except as required by applicable law, neither Prospector nor LeddarTech undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

No Offer or Solicitation

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities of Prospector or Newco, a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”).

Participants in Solicitation

Prospector, LeddarTech and Newco, and certain of their respective directors, executive officers and employees, may be deemed to be participants in the solicitation of proxies in connection with the business combination. Information about the directors and executive officers of Prospector can be found in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 31, 2023. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the business combination, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the Registration Statement and other relevant materials when they are filed with the SEC. These documents can be obtained free of charge from the source indicated above.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

GlobeNewswire Distribution ID 8969420

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 8th and 9th, 2023

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) — Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Wednesday, November 8 and Thursday, November 9, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Representatives from participating companies based in Australia, China, France, Germany, Greece, Hong Kong, Netherlands, Philippines and Taiwan will respond to questions during formal presentations and will also interact with investors via virtual trade booths. The conference is targeted to all categories of investors and analysts interested in non-US companies.

There is no fee for participants to log in, attend live presentations and/or ask questions.

Please register via this link: www.adr.db.com/dbvic

Pre-registration is suggested.

November 8 Agenda (US Eastern Standard Time):

  • 8:00 AM: Hywin Holdings Ltd (NASDAQ: HYW)
  • 8:30 AM: European Metals Holding Limited (ASX & LON: EMH, OTCQX: ERPNF, OTCQX: EMHXY)
  • 9:00 AM: Ipsen S.A. Ltd (Euronext Paris: IPN, OTC: IPSEY)
  • 9:30 AM: Heineken N.V. (Euronext Amsterdam: HEIA, OTCQX: HEINY)
  • 10:00 AM: First Pacific Company Ltd (HKEX: 142, OTC: FPAFY)
  • 10:30 AM: QBE Insurance Group Limited (ASX: QBE, OTC: QBIEY)
  • 11:00 AM: Belite Bio, Inc (NASDAQ: BLTE)

November 9 Agenda (US Eastern Standard Time):

  • 8:00 AM: iHuman Inc. (NYSE: IH)
  • 8:30 AM: HUTCHMED (China) Limited (HKEX: 13, Nasdaq & AIM:​HCM)
  • 9:00 AM: BDO Unibank, Inc (PSE: BDO, OTC: BDOUY)
  • 10:00 AM: Alpha Bank (ATHEX: ALPHA, OTC: ALBKY)
  • 10:30 PM: Hugo Boss (Xetra: BOSS, OTC: BOSSY)

The presentations will be available for replay after the Conference.

In addition to specializing in administering cross-border equity structures such as American and Global Depositary Receipts, Deutsche Bank provides corporates, financial institutions, hedge funds and supranational agencies around the world with trustee, agency, escrow and related services. The Bank offers a broad range of services for diverse products, from complex securitizations and project finance to syndicated loans, debt exchanges and restructurings.

Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.

Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes. Deutsche Bank does not prepare, review, approve or edit any presentations, statements, documents or other information or materials, whether in written, electronic or verbal form, provided by any company participating in such conference, and disclaims any responsibility for the accuracy or adequacy of any such information or materials. Deutsche Bank is not promoting, endorsing or recommending any company participating in the conference.

The Depositary Receipts have been registered pursuant to the US Securities Act of 1933 (the “Act”). The investment or investment service which is the subject of this notice is not available to retail clients as defined by the UK Financial Conduct Authority. This notice has been approved and/or communicated by Deutsche Bank AG New York. The services described in this notice are provided by Deutsche Bank Trust Company Americas (Deutsche Bank) or by its subsidiaries and/or affiliates in accordance with appropriate local registration and regulation. Deutsche Bank is providing the attached notice strictly for information purposes and makes no claims or statement, nor does it warrant or in any way represent, as to the accuracy or completeness of the details contained herein or therein. This announcement appears as a matter of record only. Neither this announcement nor the information contained herein constitutes an offer or solicitation by Deutsche Bank or any other issuer or entity for the purchase or sale of any securities nor does it constitute a solicitation to any person in any jurisdiction where solicitation would be unlawful. No part of this notice may be copied or reproduced in any way without the prior written consent of Deutsche Bank. Past results are not an indication of future performance. Copyright© November 2023 Deutsche Bank AG. All rights reserved.

For further information, please contact
Dylan Riddle
Deutsche Bank AG
Press & Media Relations
Tel. +12122504982
Cell. +1(904)3866481
Email dylan.riddle@db.com

GlobeNewswire Distribution ID 8969786

Freshworks Reports Third Quarter 2023 Results

  • Third quarter revenue grew 19% year-over-year
  • Improved business efficiency with $23.9 million in net cash provided by operating activities and $22.1 million of free cash flow in the quarter
  • Raising full year 2023 financial outlook midpoint for non-GAAP operating profit to $40 million

SAN MATEO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH), a leading software company empowering businesses to delight their customers and employees, today announced financial results for its third quarter ended September 30, 2023.

“We delivered another solid quarter of execution as we outperformed our estimates across our key financial metrics and further improved our profitability,” said Girish Mathrubootham, CEO and Founder of Freshworks. “Our market traction is fueled by continued product innovation that brings generative AI and rapid time to value to companies of all sizes.”

Third Quarter 2023 Financial Summary Results

  • Revenue: Total revenue was $153.6 million, representing growth of 19% compared to the third quarter of 2022, and 18% adjusting for constant currency.
  • GAAP (Loss) from Operations: GAAP (loss) from operations was $(38.7) million, compared to $(58.3) million in the third quarter of 2022.
  • Non-GAAP Income (Loss) from Operations: Non-GAAP income from operations was $17.4 million, compared to non-GAAP (loss) from operations of $(3.1) million in the third quarter of 2022.
  • GAAP Net (Loss) Per Share: GAAP basic and diluted net (loss) per share was $(0.11) based on 294.1 million weighted-average shares outstanding, compared to $(0.20) based on 286.7 million weighted-average shares outstanding in the third quarter of 2022.
  • Non-GAAP Net Income (Loss) Per Share: Non-GAAP diluted net income per share was $0.08 based on 302.6 million weighted-average shares outstanding, compared to non-GAAP net (loss) per share of $(0.01) based on 286.7 million weighted-average shares outstanding in the third quarter of 2022.
  • Net Cash Provided by (Used in) Operating Activities: Net cash provided by operating activities was $23.9 million, compared to net cash (used in) operating activities of $(4.2) million in the third quarter of 2022.
  • Free Cash Flow: Free cash flow was $22.1 million, compared to $(7.2) million in the third quarter of 2022.
  • Cash, Cash Equivalents and Marketable Securities: Cash, cash equivalents, and marketable securities were $1.16 billion as of September 30, 2023.

A description of non-GAAP financial measures is contained in the section titled “Explanation of Non-GAAP Financial Measures” below and a reconciliation of GAAP to non-GAAP financial measures is contained in the tables below.

Third Quarter Key Metrics and Recent Business Highlights

  • Number of customers contributing more than $5,000 in ARR was 19,551, an increase of 17% year-over-year and 16% adjusting for constant currency.
  • Net dollar retention rate was 108% (106% adjusting for constant currency), compared to 108% in the second quarter of 2023 and 107% in the third quarter of 2022. Constant currency net dollar retention rate was 107% in the second quarter of 2023 and 113% in the third quarter of 2022.
  • Welcomed more customers to the Freshworks community including: ASPCA, Cenveo, Giant Eagle Inc., Kelly Benefits, Qualfon, Salvation Army Australia and Tri Pointe Homes.
  • Unveiled an AI-powered Customer Service Suite which brings together self-service bots, agent-led conversational messaging, and automated ticketing management in an all-in-one solution by uniting Freshchat™, Freshdesk™, and the company’s generative artificial intelligence technology, Freddy AI.
  • Appointed Johanna Jackman as Chief People Officer and announced Mika Yamamoto to join as Chief Customer and Marketing Officer.
  • Held an Investor Day in San Francisco on September 7, 2023, providing an update on our vision, product plans, growth strategy and financial model.

Financial Outlook

We are providing estimates for the fourth quarter and full year 2023 based on current market conditions and expectations. The revenue growth rates are adjusted for constant currency to provide better visibility into the underlying business trends. We emphasize that these estimates are subject to various important cautionary factors referenced in the section entitled “Forward-Looking Statements” below.

For the fourth quarter and full year 2023, we currently expect the following results:

($ in millions, except per share data) Fourth Quarter 2023 Full Year 2023
Revenue(1) $156.7 – $159.3 $593.0 – $595.5
Year-over-year growth 18% – 20% 19% – 20%
Adjusting for constant currency(2) 17% – 19% 19% – 20%
Non-GAAP income from operations(1) $5.5 – $8.5 $38.5 – $41.5
Non-GAAP net income per share(3) $0.04 – $0.06 $0.23 – $0.25
(1) Revenue and non-GAAP income from operations are based on exchange rates as of October 27, 2023 for currencies other than USD.
(2) Revenue growth rates adjusted for constant currency are based on average exchange rates in effect during the comparison period for currencies other than USD. See the section entitled “Explanation of non-GAAP Financial Measures” and the table entitled “Reconciliation of Selected GAAP Measures to non‑GAAP Measures” for a reconciliation of GAAP to non‑GAAP measures for the historical periods provided in this release.
(3) Non-GAAP net income per share was estimated assuming 303.3 million and 300.1 million weighted-average shares outstanding for the fourth quarter and full year 2023, respectively.

These statements are forward-looking and actual results may differ materially. Refer to the “Forward-Looking Statements” safe harbor section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.

We have not reconciled our estimates for non-GAAP financial measures to GAAP due to the uncertainty and potential variability of expenses that may be incurred in the future. As a result, a reconciliation is not available without unreasonable effort and we are unable to address the probable significance of the unavailable information. We have provided a reconciliation of other GAAP to non-GAAP financial measures in the financial statement tables for our third quarter and first nine months of 2023 and 2022 non-GAAP results included in this press release.

Webcast and Conference Call Information

We will host a conference call for investors on October 31, 2023 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss the company’s financial results and business highlights. Investors are invited to listen to a live audio webcast of the conference call by visiting the investor relations website at ir.freshworks.com. A replay of the audio webcast will be available shortly after the call on the Freshworks Investor Relations website and will be available for twelve months thereafter.

Explanation of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), this press release and the accompanying tables contain non-GAAP financial measures, including revenue adjusted for constant currency, non-GAAP gross profit, non-GAAP gross margin, non-GAAP sales and marketing expense, non-GAAP research and development expense, non-GAAP general and administrative expense, non-GAAP income (loss) from operations, non-GAAP operating margin, non-GAAP net income (loss) per share, non-GAAP net income (loss) attributable to common stockholders, and free cash flow. This press release and the accompanying tables also contain certain non-GAAP metrics, including annual recurring revenue, net dollar retention rates, revenue growth rates, and related presentation thereof adjusted for constant currency.

We adjust revenue and related growth rates for constant currency to provide a framework for assessing business performance excluding the effect of foreign currency rate fluctuations. To present this information, current period results for currencies other than USD are converted into USD at the average exchange rates in effect during the comparison period (for Q3 2022, the average exchange rates in effect for our major currencies were 1 USD to 1.01 EUR and 1 USD to 1.18 GBP), rather than the actual average exchange rates in effect during the current period (for Q3 2023, the average exchange rates in effect for our major currencies were 1 USD to 1.09 EUR and 1 USD to 1.27 GBP).

We use these non-GAAP measures in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies and to communicate with our board of directors concerning our financial performance. We believe these non-GAAP measures provide investors consistency and comparability with our past financial performance and facilitate period-to-period comparisons of our operating results. We believe these non-GAAP measures are useful in evaluating our operating performance compared to that of other companies in our industry, as they generally eliminate the effects of certain items that may vary for different companies for reasons unrelated to overall operating performance.

Investors, however, are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. The non-GAAP measures we use may be different from non-GAAP financial measures used by other companies, limiting their usefulness for comparison purposes. We compensate for these limitations by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.

We exclude the following items from one or more of our non-GAAP financial measures, including the related income tax effect of these adjustments:

  • Stock-based compensation expense. We exclude stock-based compensation, which is a non-cash expense, from certain of our non-GAAP financial measures because we believe that excluding this expense provides meaningful supplemental information regarding operational performance. In particular, stock-based compensation expense is not comparable across companies given the variety of valuation methodologies and assumptions.
  • Employer payroll taxes on employee stock transactions. We exclude the amount of employer payroll taxes on equity awards from certain of our non-GAAP financial measures because they are dependent on our stock price at the time of vesting or exercise and other factors that are beyond our control and do not believe these expenses have a direct correlation to the operation of our business.
  • Amortization of acquired intangibles. We exclude amortization of acquired intangibles, which is a non-cash expense, from certain of our non-GAAP financial measures. Our expenses for amortization of acquired intangibles are inconsistent in amount and frequency because they are significantly affected by the timing, size of acquisitions, and the allocation of purchase price. We exclude these amortization expenses because we do not believe these expenses have a direct correlation to the operation of our business.

We define free cash flow as net cash provided by (used in) operating activities, less purchases of property and equipment and capitalized internal-use software. We believe that free cash flow is a useful indicator of liquidity as it measures our ability to generate cash from our core operations after purchases of property and equipment. Free cash flow is a measure to determine, among other things, cash available for strategic initiatives, including further investments in our business and potential acquisitions of businesses.

Operating Metrics

Number of Customers Contributing More Than $5,000 in ARR. We define ARR as the sum total of the revenue we would contractually expect to recognize over the next 12 months from all customers at a point in time, assuming no increases, reductions or cancellations in their subscriptions. We define our total customers contributing more than $5,000 in ARR as of a particular date as the number of business entities or individuals, represented by a unique domain or a unique email address, with one or more paid subscriptions to one or more of our products that contributed more than $5,000 in ARR.

Net Dollar Retention Rate. To calculate net dollar retention rate as of a given date, we first determine Entering ARR, which is ARR from the population of our customers as of 12 months prior to the end of the reporting period. We then calculate the Ending ARR from the same set of customers as of the end of the reporting period. We then divide the Ending ARR by the Entering ARR to arrive at our net dollar retention rate. Ending ARR includes upsells, cross-sells, and renewals during the measurement period and is net of any contraction or attrition over this period.

We also adjust the above operating metrics, growth rates of customers contributing more than $5,000 in ARR and related presentation thereof for constant currency to provide a framework for assessing our business performance excluding the effects of foreign currency rates fluctuations. To present this information, the Ending ARR of the current period in currencies other than USD is converted into USD at the exchange rates in effect at the end of the comparison period (for Q3 2022, the period end exchange rates in effect for our major currencies were 1 USD to 0.98 EUR and 1 USD to 1.12 GBP), rather than the actual exchange rates in effect at the end of the current period (for Q3 2023, the period end exchange rates in effect for our major currencies were 1 USD to 1.06 EUR and 1 USD to 1.22 GBP).

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, our GAAP and non-GAAP estimates for the fourth quarter and full year 2023, our financial outlook, the value of our products to customers, the results of our focus on product innovation efforts and the usefulness of the measures by which we evaluate our business, among other things. These forward-looking statements are based on our current expectations, estimates and projections about our business and industry, including our financial outlook and macroeconomic uncertainties, management’s beliefs and certain assumptions made by the company, all of which are subject to change. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “future,” “believe,” “expect,” “may,” “will,” “intend” “estimate,” “continue,” “anticipate,” “could,” “would,” “projects,” “plans,” “targets” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, many of which involve factors or circumstances that are beyond our control, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. Factors that may cause actual results to differ materially include our ability to achieve our long-term plans and key initiatives; our ability to sustain or manage any future growth effectively; our ability to attract and retain customers or expand sales to existing customers; delays in product development or deployments or the success of such products; the failure to deliver competitive service offerings and lack of market acceptance of any offerings delivered; the impact to the economy, our customers and our business due to global economic conditions, including market volatility, foreign exchange rates, and impact of inflation; the timeframes for and severity of the impact of any weakened global economic conditions on our customers’ purchasing and renewal decisions, which may extend the length of our sales cycles or adversely affect our industry; our history of net losses and ability to achieve or sustain profitability, as well as the other potential factors described under “Risk Factors” included in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, and our Annual Report on Form 10-K for the year ended December 31, 2022, as such factors may be updated from time to time in our periodic and other documents of Freshworks Inc. filed with the Securities and Exchange Commission from time to time (available at www.sec.gov), including our Quarterly Report on Form 10-Q that will be filed for the quarter ended September 30, 2023.

We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof and are based on information available to us at the time the statements are made and/or management’s good faith belief as of that time with respect to future events. We assume no obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release, except as required by law.

About Freshworks Inc.

Freshworks Inc., (NASDAQ: FRSH) creates AI-boosted business software anyone can use. Purpose-built for IT, customer support, and sales and marketing teams, our products are designed to let everyone work more efficiently and deliver more value for immediate business impact. Headquartered in San Mateo, California, Freshworks operates around the world to serve more than 66,000 customers, including American Express, Blue Nile, Bridgestone, Databricks, Fila, and OfficeMax. For the freshest company news, visit www.freshworks.com and follow us on Facebook, LinkedIn, and X.

Investor Relations Contact:
Joon Huh
IR@freshworks.com
650-988-5699

Media Relations Contact:
Jayne Gonzalez
PR@freshworks.com
408-348-1087

© 2023 Freshworks Inc. All Rights Reserved. Freshworks and its associated logo is a trademark of Freshworks Inc. All other company, brand and product names may be trademarks or registered trademarks of their respective companies. Nothing in this press release should be construed to the contrary, or as an approval, endorsement or sponsorship by any third parties of Freshworks Inc. or any aspect of this press release.

FRESHWORKS INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(in thousands, except per share data)
(unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Revenue $ 153,550 $ 128,760 $ 436,321 $ 364,829
Cost of revenue(1) 26,263 24,179 76,360 70,616
Gross profit 127,287 104,581 359,961 294,213
Operating expense:
Research and development(1) 34,885 35,871 101,922 100,885
Sales and marketing(1) 90,673 86,865 265,458 248,369
General and administrative(1) 40,464 40,133 122,712 117,723
Total operating expenses 166,022 162,869 490,092 466,977
Loss from operations (38,735 ) (58,288 ) (130,131 ) (172,764 )
Interest and other income, net 10,993 2,249 31,688 2,609
Loss before income taxes (27,742 ) (56,039 ) (98,443 ) (170,155 )
Provision for income taxes 3,291 1,804 10,912 6,500
Net loss (31,033 ) (57,843 ) (109,355 ) (176,655 )
Net loss per share – basic and diluted $ (0.11 ) $ (0.20 ) $ (0.37 ) $ (0.62 )
Weighted average shares used in computing net loss per share – basic and diluted 294,146 286,697 292,103 283,258

______________________
(1)        Includes stock-based compensation expense as follows (in thousands):

Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Cost of revenue $ 1,710 $ 1,772 $ 5,137 $ 5,212
Research and development 9,623 10,318 28,662 26,446
Sales and marketing 18,757 16,635 51,786 44,204
General and administrative 25,035 25,167 74,482 74,790
Total stock-based compensation expense, net of amounts capitalized $ 55,125 $ 53,892 $ 160,067 $ 150,652
FRESHWORKS INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 30,
2023
December 31,
2022
(unaudited)
Assets
Current assets:
Cash and cash equivalents $ 458,249 $ 304,083
Marketable securities 706,472 843,405
Accounts receivable, net 80,294 70,470
Deferred contract acquisition costs 22,155 20,139
Prepaid expenses and other current assets 52,331 38,913
Total current assets 1,319,501 1,277,010
Property and equipment, net 22,928 24,139
Operating lease right-of-use assets 32,246 33,024
Deferred contract acquisition costs, noncurrent 19,067 19,536
Goodwill 6,181 6,181
Deferred tax assets 8,535 8,689
Other assets 9,630 11,637
Total assets $ 1,418,088 $ 1,380,216
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 2,688 $ 5,908
Accrued liabilities 54,664 59,008
Deferred revenue 246,085 205,626
Income tax payable 2,284 1,150
Total current liabilities 305,721 271,692
Operating lease liabilities, non-current 26,949 28,174
Other liabilities 26,934 28,532
Total liabilities 359,604 328,398
Stockholders’ equity:
Common stock 3 3
Additional paid-in capital 4,675,801 4,562,319
Accumulated other comprehensive loss (4,892 ) (7,431 )
Accumulated deficit (3,612,428 ) (3,503,073 )
Total stockholders’ equity 1,058,484 1,051,818
Total liabilities and stockholders’ equity $ 1,418,088 $ 1,380,216
FRESHWORKS INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Cash Flows from Operating Activities:
Net loss $ (31,033 ) $ (57,843 ) $ (109,355 ) $ (176,655 )
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization 2,984 2,795 9,098 8,574
Amortization of deferred contract acquisition costs 6,131 4,625 17,600 13,321
Non-cash lease expense 1,965 1,567 5,692 4,463
Stock-based compensation 55,125 53,892 160,067 150,652
Premium (discount) amortization on marketable securities (4,286 ) (533 ) (12,108 ) 564
Change in fair value of equity securities (4 ) 10 (65 ) (75 )
Deferred income taxes 113 309
Other 123 273 175 1,468
Changes in operating assets and liabilities:
Accounts receivable (6,404 ) (1,432 ) (10,003 ) (5,256 )
Deferred contract acquisition costs (6,391 ) (6,913 ) (19,147 ) (19,554 )
Prepaid expenses and other assets (5,222 ) (3,929 ) (11,793 ) (12,374 )
Accounts payable 1,002 (2,416 ) (3,219 ) (1,962 )
Accrued and other liabilities 2,331 668 (3,150 ) 3,874
Deferred revenue 11,727 8,173 40,459 30,796
Operating lease liabilities (4,135 ) (3,160 ) (9,052 ) (7,837 )
Net cash provided by (used in) operating activities 23,913 (4,223 ) 55,312 (9,692 )
Cash Flows from Investing Activities:
Purchases of property and equipment (278 ) (1,907 ) (990 ) (5,288 )
Proceeds from sale of property and equipment 33 49 91 132
Capitalized internal-use software (1,564 ) (1,106 ) (5,075 ) (3,828 )
Purchases of marketable securities (161,261 ) (250,301 ) (653,679 ) (538,501 )
Sales of marketable securities 92,786
Maturities and redemptions of marketable securities 265,214 113,055 805,933 293,625
Net cash provided by (used in) investing activities 102,144 (140,210 ) 146,280 (161,074 )
Cash Flows from Financing Activities:
Proceeds from issuance of common stock under employee stock purchase plan, net 4,312 7,011
Proceeds from exercise of stock options 16 2 61 98
Payment of withholding taxes on net share settlement of equity awards (24,045 ) (13,367 ) (51,782 ) (151,716 )
Payment of deferred offering costs (109 )
Net cash used in financing activities (24,029 ) (13,365 ) (47,409 ) (144,716 )
Net increase (decrease) in cash, cash equivalents and restricted cash 102,028 (157,798 ) 154,183 (315,482 )
Cash, cash equivalents and restricted cash, beginning of period 356,313 590,180 304,158 747,864
Cash, cash equivalents and restricted cash, end of period $ 458,341 $ 432,382 $ 458,341 $ 432,382
FRESHWORKS INC.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
September 30,
2023 2022 Growth Rates
Revenue
GAAP revenue $ 153,550 $ 128,760 19 %
Effects of foreign currency rate fluctuations (1,908 )
Revenue adjusted for constant currency $ 151,642 18 %
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023 2022 2023 2022
Reconciliation of gross profit and gross margin:
GAAP gross profit $ 127,287 $ 104,581 $ 359,961 $ 294,213
Non-GAAP adjustments:
Stock-based compensation expense 1,710 1,772 5,137 5,212
Employer payroll taxes on employee stock transactions 40 58 113 25
Amortization of acquired intangibles 175 158 1,015
Non-GAAP gross profit $ 129,037 $ 106,586 $ 365,369 $ 300,465
GAAP gross margin 82.9 % 81.2 % 82.5 % 80.6 %
Non-GAAP gross margin 84.0 % 82.8 % 83.7 % 82.4 %
Reconciliation of operating expenses:
GAAP research and development $ 34,885 $ 35,871 $ 101,922 $ 100,885
Non-GAAP adjustments:
Stock-based compensation expense (9,623 ) (10,318 ) (28,662 ) (26,446 )
Employer payroll taxes on employee stock transactions (47 ) (25 ) (236 ) 127
Non-GAAP research and development $ 25,215 $ 25,528 $ 73,024 $ 74,566
GAAP research and development as percentage of revenue 22.7 % 27.9 % 23.4 % 27.7 %
Non-GAAP research and development as percentage of revenue 16.4 % 19.8 % 16.7 % 20.4 %
GAAP sales and marketing $ 90,673 $ 86,865 $ 265,458 $ 248,369
Non-GAAP adjustments:
Stock-based compensation expense (18,757 ) (16,635 ) (51,786 ) (44,204 )
Employer payroll taxes on employee stock transactions (661 ) (746 ) (1,673 ) (954 )
Amortization of acquired intangibles (101 ) (145 ) (300 )
Non-GAAP sales and marketing $ 71,255 $ 69,383 $ 211,854 $ 202,911
GAAP sales and marketing as percentage of revenue 59.1 % 67.5 % 60.8 % 68.1 %
Non-GAAP sales and marketing as percentage of revenue 46.4 % 53.9 % 48.6 % 55.6 %
GAAP general and administrative $ 40,464 $ 40,133 $ 122,712 $ 117,723
Non-GAAP adjustments:
Stock-based compensation expense (25,035 ) (25,167 ) (74,482 ) (74,790 )
Employer payroll taxes on employee stock transactions (260 ) (165 ) (744 ) (457 )
Non-GAAP general and administrative $ 15,169 $ 14,801 $ 47,486 $ 42,476
GAAP general and administrative as percentage of revenue 26.4 % 31.2 % 28.1 % 32.3 %
Non-GAAP general and administrative as percentage of revenue 9.9 % 11.5 % 10.9 % 11.6 %
Reconciliation of operating loss and operating margin:
GAAP loss from operations $ (38,735 ) $ (58,288 ) $ (130,131 ) $ (172,764 )
Non-GAAP adjustments:
Stock-based compensation expense 55,125 53,892 160,067 150,652
Employer payroll taxes on employee stock transactions 1,008 994 2,766 1,309
Amortization of acquired intangibles 276 303 1,315
Non-GAAP income (loss) from operations $ 17,398 $ (3,126 ) $ 33,005 $ (19,488 )
GAAP operating margin (25.2 )% (45.3 )% (29.8 )% (47.4 )%
Non-GAAP operating margin 11.3 % (2.4 )% 7.6 % (5.3 )%
Reconciliation of net loss attributable to common stockholders:
GAAP net loss attributable to common stockholders – basic and diluted $ (31,033 ) $ (57,843 ) $ (109,355 ) $ (176,655 )
Non-GAAP adjustments:
Stock-based compensation expense 55,125 53,892 160,067 150,652
Employer payroll taxes on employee stock transactions 1,008 994 2,766 1,309
Amortization of acquired intangibles 276 303 1,315
Income tax adjustments 479 565 1,617 1,528
Non-GAAP net income (loss) attributable to common stockholders – basic and diluted $ 25,579 $ (2,116 ) $ 55,398 $ (21,851 )
Reconciliation of net loss per share – diluted:
GAAP net loss per share – diluted $ (0.11 ) $ (0.20 ) $ (0.37 ) $ (0.62 )
Non-GAAP adjustments:
Stock-based compensation expense 0.19 0.19 0.55 0.53
Employer payroll taxes on employee stock transactions 0.01
Amortization of acquired intangibles
Income tax adjustments 0.01 0.01
Non-GAAP net income (loss) per share – diluted $ 0.08 $ (0.01 ) $ 0.19 $ (0.08 )
Weighted-average shares used in computing GAAP net loss per share – diluted 294,146 286,697 292,103 283,258
Weighted-average shares used in computing non-GAAP net income (loss) per share – diluted(1) 302,597 286,697 298,821 283,258
Computation of free cash flow:
Net cash provided by provided by (used in) operating activities $ 23,913 $ (4,223 ) $ 55,312 $ (9,692 )
Less:
Purchases of property and equipment (278 ) (1,907 ) (990 ) (5,288 )
Capitalized internal-use software (1,564 ) (1,106 ) (5,075 ) (3,828 )
Free cash flow $ 22,071 $ (7,236 ) $ 49,247 $ (18,808 )
Net cash provided by (used in) investing activities $ 102,144 $ (140,210 ) $ 146,280 $ (161,074 )
Net cash used in financing activities $ (24,029 ) $ (13,365 ) $ (47,409 ) $ (144,716 )
(1) Diluted net income (loss) per share attributable to common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result. The company considers its stock options and RSUs as potential common stock equivalents but excluded them from the computation of GAAP diluted net loss per share attributable to common stockholders, as their effect was antidilutive. For the three months ended September 30, 2023, potentially dilutive shares of 8.5 million shares were included in the weighted average shares used in computing non-GAAP net income per share. For the nine months ended September 30, 2023, potentially dilutive shares of 6.7 million shares were included in the weighted average shares used in computing non-GAAP net income per share.

GlobeNewswire Distribution ID 8969525

Azerion completes refinancing of outstanding senior secured bonds maturing in April 2024

NOT FOR DISTRIBUTION TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”)) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

Amsterdam, 31 October 2023 – Azerion Group N.V. (the “Company”) is pleased to confirm the completion of the refinancing of its outstanding senior secured bonds maturing in April 2024 with the successful early redemption of all outstanding senior secured fixed rate bonds with ISIN SE0015837794About Azerion

Founded in 2014, Azerion (EURONEXT: AZRN) is one of Europe’s largest digital advertising and entertainment media platforms. We bring global scaled audiences to advertisers in an easy and cost-effective way, delivered through our proprietary technology, in a safe, engaging, and high-quality environment, utilizing our strategic portfolio of owned and operated content with entertainment and other digital publishing partners.

Having its roots in Europe and with its headquarters in Amsterdam, Azerion has commercial teams based in over 26 cities around the world to closely support our clients and partners to find and execute creative ways to make a real impact through advertising.

For more information visit: www.azerion.com

For further information, please contact:

Andrew Buckman
VP Investor Relations
ir@azerion.com

Media: press@azerion.com

Disclaimer

This communication does not constitute an offer to sell, or a solicitation of an offer to buy, any securities or any other financial instruments.

This communication does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any New Bonds or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with or act as an inducement to enter into, any contract or commitment whatsoever.

In particular, this communication does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, or form part of any offer, invitation or solicitation to purchase, securities to any person located or resident in the United States or to any U.S. Person (as defined in Regulation S under the U.S. Securities Act). The securities referred to herein have not been, and will not be, registered pursuant to U.S. Securities Act or any securities laws in any state or other jurisdiction in the United Sates and may not be offered, sold, accepted, exercised, re-sold, renounced, transferred or delivered, whether directly or indirectly, in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act. No public offering of securities is being, has been, or will be made in the United States.

This communication is made accessible on the basis that any offers of securities referred to herein in any Member State of the EEA will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of such securities. The New Bonds have, with respect to persons in Member States of EEA, only been offered to persons who are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Regulation and Section 1:1 of the Dutch Financial Supervision Act. The expression “Prospectus Regulation” means Regulation No. 1129/2017.

In the United Kingdom, the material is made accessible on the basis that any offers of securities referred to herein will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to publish a prospectus for offers of such securities. The New Bonds have, with respect to persons in the United Kingdom, only been offered to persons who are qualified investors within the meaning of Article 2(1)(e) of the UK Prospectus Regulation. The expression “UK Prospectus Regulation” means Regulation (EU) 2017/1129 as it forms part of retained EU law as defined in the EU (Withdrawal) Act 2018.

The release, publication or distribution of the material may be restricted by law and persons in such jurisdictions in which a release, publication or distribution of the material should therefore inform themselves about, and observe, any such restrictions. This press release may include projections and other “forward-looking” statements within the meaning of applicable securities laws. Any such projections or statements reflect the current views of the Company about future events and financial performance. No assurances can be given that such events or performance will occur as projected and actual results may differ materially from these projections.

GlobeNewswire Distribution ID 1000896970

King Faisal Specialist Hospital and Research Centre เฉลิมฉลองความสำเร็จในการรักษาผู้ป่วยมะเร็งเม็ดเลือดขาวลิมโฟไซติก 100 รายโดยใช้ CAR T-Cells

ริยาด ซาอุดีอาระเบีย, Oct. 31, 2023 (GLOBE NEWSWIRE) — ในก้าวใหม่ที่ทำให้ผู้ป่วยโรคมะเร็งได้รับความหวังอันริบหรี่และเส้นชีวิต King Faisal Specialist Hospital and Research Centre (KFSH&RC) ได้เฉลิมฉลองความสำเร็จในการรักษาผู้ป่วยรายที่ 100 ที่เป็นมะเร็งเม็ดเลือดขาวชนิดต่อมน้ำเหลืองโดยใช้การบำบัดด้วย Chimeric Antigen Receptor T-cell (CAR T-cell) การรักษานี้สอดคล้องกับวิสัยทัศน์ของ KFSH&RC ที่ต้องการเป็นทางเลือกที่ดีที่สุดสำหรับการดูแลสุขภาพเฉพาะทาง

การบำบัดด้วย CAR T-cell เป็นนวัตกรรมการรักษาที่ช่วยเพิ่มความสามารถของทีเซลล์ในการรับรู้และทำลายเซลล์มะเร็งหลังจากการดัดแปลงพันธุกรรมในห้องปฏิบัติการ เพื่อปรับปรุงความสามารถในการกำหนดเป้าหมาย วิธีการนี้เอาชนะความท้าทายในการแยกแยะระหว่างเซลล์มะเร็งและเซลล์ปกติ โดยเสนอวิธีการที่มีความหวังในการรักษามะเร็งเม็ดเลือดขาวชนิดต่อมน้ำเหลือง

KFSH&RC เน้นย้ำว่าเทคโนโลยีที่เป็นนวัตกรรมนี้ให้ความหวังแก่ผู้ป่วยมะเร็งเม็ดเลือดขาวและเนื้องอกของต่อมน้ำเหลืองที่ดื้อยา โดยเฉพาะอย่างยิ่งผู้ที่ไม่สามารถรักษาด้วยวิธีดั้งเดิมได้อย่างมีประสิทธิภาพ

ในฐานะที่ KFSH&RC เป็นพันธมิตรด้านการดูแลสุขภาพเชิงกลยุทธ์ องค์กรจึงกำลังแบ่งปันข้อมูลเกี่ยวกับการบำบัดด้วย CAR T-cell ผลกระทบเชิงบวกต่อการปรับปรุงการดูแลสุขภาพ ตลอดจนโซลูชันและนวัตกรรมด้านการดูแลสุขภาพต่าง ๆ ในระหว่างงาน Global Health Exhibition ที่จัดขึ้นในกรุงริยาด ตั้งแต่วันที่ 29 ถึง 31 ตุลาคม

โรงพยาบาล KFSH&RC อธิบายว่าการบำบัดขั้นสูงนี้ประกอบด้วย 4 ขั้นตอน คือ การแยกเลือดจากผู้ป่วยเพื่อให้ได้เซลล์เฉพาะ จากนั้นจึงดำเนินการดัดแปลงพันธุกรรมในห้องทดลองเป็นเวลา 3-4 สัปดาห์

ไม่นานก่อนการบำบัดด้วย CAR T-cell ผู้ป่วยจะได้รับเคมีบำบัดในปริมาณต่ำเพื่อเพิ่มประสิทธิภาพและความสามารถของร่างกายในการต่อสู้กับมะเร็ง หลังจากนั้นจะทำการ CAR T-cell เข้าไปในแขนของผู้ป่วย ซึ่งจะได้รับการติดตามอย่างใกล้ชิดเป็นเวลาสี่สัปดาห์เพื่อให้แน่ใจว่าร่างกายจะปรับตัวได้

การใช้การรักษาขั้นสูงนี้ในราชอาณาจักรถือเป็นการเสริมคุณภาพให้กับการรักษาพยาบาลเฉพาะทาง โดยช่วยลดภาระทางการเงิน ทางสังคม และทางสุขภาพในการส่งผู้ป่วยดังกล่าวไปต่างประเทศ ซึ่งสอดคล้องกับวิสัยทัศน์ Saudi Vision 2030 ของซาอุดีอาระเบียและวัตถุประสงค์ด้านการดูแลสุขภาพของประเทศ

King Faisal Specialist Hospital and Research Centre ได้รับการยอมรับทั่วโลกสำหรับการนำเสนอรูปแบบการรักษาขั้นสูงนี้ เนื่องจากโปรแกรมการรักษาที่ครอบคลุมซึ่งมีผู้เชี่ยวชาญทางการแพทย์ การพยาบาล เภสัชกรรม ห้องปฏิบัติการ และทางสังคม ซึ่งได้รับการสนับสนุนโดยโครงสร้างพื้นฐานแบบครบวงจร

KFSH&RC เป็นผู้นำระดับโลกในด้านการดูแลสุขภาพเฉพาะทาง นวัตกรรม การวิจัยขั้นสูง และการศึกษาทางการแพทย์ องค์มีจุดมุ่งหมายเพื่อพัฒนาเทคโนโลยีทางการแพทย์และยกระดับมาตรฐานการดูแลสุขภาพทั่วโลกผ่านการร่วมมือกับสถาบันชั้นนำทั้งในระดับท้องถิ่น ระดับภูมิภาค และระดับนานาชาติในสาขาทางคลินิก การวิจัย และการศึกษา

ข้อมูลการติดต่อ:
kfshrc@mcsaatchi.com

สามารถดูรูปภาพประกอบประกาศนี้ได้ที่ https://www.globenewswire.com/NewsRoom/AttachmentNg/9693817f-f8f6-4535-b14c-41f6801f16f7

GlobeNewswire Distribution ID 8969530

King Faisal Specialist Hospital and Research Centre มุ่งหวังที่จะบรรลุความพึ่งตนเองได้ในด้านเภสัชรังสีในราชอาณาจักร

ริยาด ซาอุดีอาระเบีย, Oct. 31, 2023 (GLOBE NEWSWIRE) — ในช่วงสี่ทศวรรษที่ผ่านมา แผนกไซโคลตรอนและเภสัชรังสีที่ King Faisal Specialist Hospital and Research Centre (KFSH&RC) ได้ตอบสนองความต้องการของศูนย์การแพทย์ในท้องถิ่นและระดับภูมิภาคสำหรับด้านเภสัชรังสีที่ใช้ในการวินิจฉัยและรักษาโรคเฉพาะทางต่าง ๆ

นับตั้งแต่ก่อตั้ง แผนกนี้ได้ผลิตเภสัชภัณฑ์รังสีมากกว่า 25 ประเภท โดยมีกำลังการผลิตในด้านการเตรียมการด้านเภสัชภัณฑ์รังสีมากกว่า 600,000 รายการ แผนกนี้ยังคงจัดหาผลิตภัณฑ์ให้กับศูนย์การแพทย์เฉพาะทางในซาอุดิอาระเบียมากกว่า 50 แห่ง โดยมีเป้าหมายเพื่อให้บรรลุถึงความพึ่งตนเองได้ในด้านเภสัชรังสีในราชอาณาจักรซาอุดีอาระเบียด้วย

KFSH&RC ได้ตอกย้ำถึงบทบาทบุกเบิกของแผนกเวชศาสตร์นิวเคลียร์ในระหว่างนิทรรศการ Global Health Exhibition ซึ่งได้เริ่มต้นขึ้นเมื่อวานนี้ในเมืองหลวงริยาด โดยโรงพยาบาลแห่งนี้ได้เข้าร่วมในฐานะพันธมิตรเชิงกลยุทธ์ด้านสุขภาพ ซึ่งรวมถึงการเพิ่มขีดความสามารถของผู้ให้บริการด้านสุขภาพทั้งในด้านการวิจัยและการศึกษา ตลอดจนการทำให้มั่นใจในคุณภาพในการผลิตและจำหน่ายเภสัชภัณฑ์รังสีไปยังโรงพยาบาลทั่วราชอาณาจักรและต่างประเทศ

แผนกไซโคลตรอนและเภสัชรังสีมีความมุ่งมั่นที่จะเป็นศูนย์วินิจฉัยและถ่ายภาพโมเลกุล และเป็นสถานที่แห่งแรกสำหรับเครื่องกำเนิดไฟฟ้า Technetium-99m (Tc-99m) ในราชอาณาจักร แผนกนี้ได้ดำเนินการวิจัยเพื่อพัฒนาเภสัชภัณฑ์รังสีคุณภาพสูงสำหรับ KFSH&RC และโรงพยาบาลอื่น ๆ ทั่วราชอาณาจักร เพื่อตอบสนองความต้องการด้านการรักษาพยาบาลของผู้ป่วย แผนกดังกล่าวได้ปฏิบัติตามมาตรฐานคุณภาพระดับสูงสำหรับการควบคุมคุณภาพและการประกันคุณภาพแบบอัตโนมัติ ในขณะเดียวกันก็มุ่งมั่นที่จะพัฒนาเทคโนโลยีไซโคลตรอน การผลิตเภสัชภัณฑ์รังสีที่แม่นยำ และการพัฒนาเภสัชภัณฑ์รังสีที่ใช้ในการตรวจเอกซเรย์ด้วยโพสิตรอน/เอกซเรย์ด้วยคอมพิวเตอร์ (PET/CT)

แผนกนี้เน้นย้ำด้านคุณภาพอย่างมีนัยสำคัญ โดยมีหน่วยควบคุมและจัดการคุณภาพผลิตภัณฑ์แบบบูรณาการ วัสดุการผลิตที่เป็นไปตามหลักปฏิบัติที่ดีในการผลิต (Good Manufacturing Practices หรือ GMP) มาตรฐานขององค์การอาหารและยาแห่งซาอุดิอาระเบีย (Saudi Food and Drug Authority หรือ SFDA) และมาตรฐานระบบการจัดการคุณภาพสากล ISO 9001 กระบวนการดำเนินงานทั้งหมดอยู่ภายใต้การเฝ้าสังเกตอย่างเข้มงวดเพื่อการประเมินวัสดุเป็นระยะ เพื่อให้มั่นใจว่ากระบวนการดังกล่าวมีความเหมาะสมอยู่ตลอดเวลา แนวทางนี้นำไปสู่อัตราความพึงพอใจของลูกค้าที่โดดเด่นมากเกินกว่า 95%

KFSH&RC ได้รับการยอมรับทั่วโลกในด้านการให้บริการดูแลสุขภาพเฉพาะทาง และเป็นผู้นำในด้านนวัตกรรม การวิจัยทางการแพทย์ขั้นสูง และการศึกษาทางการแพทย์ สถาบันมุ่งมั่นที่จะพัฒนาเทคโนโลยีทางการแพทย์และยกระดับมาตรฐานการดูแลสุขภาพทั่วโลก โดยร่วมมือกับองค์กรชั้นนำระดับท้องถิ่น ระดับภูมิภาค และระดับนานาชาติเพื่อให้บริการระดับโลกในด้านคลินิก การวิจัย และการศึกษา

ข้อมูลการติดต่อ:

kfshrc@mcsaatchi.com

สามารถดูรูปภาพประกอบประกาศนี้ได้ที่

https://www.globenewswire.com/NewsRoom/AttachmentNg/ad78d2ea-0d15-45ae-a3bd-cd25f7bf7ab9

https://www.globenewswire.com/NewsRoom/AttachmentNg/1d1f90e9-3a44-43cf-8812-af6760e2d0b2

GlobeNewswire Distribution ID 8969468